164 related articles for article (PubMed ID: 12446929)
1. Topographic regulation of kinase activity in Alzheimer's disease brains.
Grant P; Pant HC
J Alzheimers Dis; 2002 Aug; 4(4):269-81. PubMed ID: 12446929
[TBL] [Abstract][Full Text] [Related]
2. Topographic regulation of cytoskeletal protein phosphorylation by multimeric complexes in the squid giant fiber system.
Grant P; Diggins M; Pant HC
J Neurobiol; 1999 Jul; 40(1):89-102. PubMed ID: 10398074
[TBL] [Abstract][Full Text] [Related]
3. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
5. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
Wu R; Gu J; Zhou D; Tung YC; Jin N; Chu D; Hu W; Wegiel J; Gong CX; Iqbal K; Liu F
J Alzheimers Dis; 2021; 79(4):1647-1659. PubMed ID: 33459649
[TBL] [Abstract][Full Text] [Related]
6. Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain.
Veeranna ; Shetty KT; Takahashi M; Grant P; Pant HC
Brain Res Mol Brain Res; 2000 Mar; 76(2):229-36. PubMed ID: 10762698
[TBL] [Abstract][Full Text] [Related]
7. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
[TBL] [Abstract][Full Text] [Related]
8. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
9. P13suc1 associates with a cdc2-like kinase in a multimeric cytoskeletal complex in squid axoplasm.
Takahashi M; Amin N; Grant P; Pant HC
J Neurosci; 1995 Sep; 15(9):6222-9. PubMed ID: 7666204
[TBL] [Abstract][Full Text] [Related]
10. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori K; Uchida T
J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
[TBL] [Abstract][Full Text] [Related]
11. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
12. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.
Norris PJ; Faull RL; Emson PC
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):36-49. PubMed ID: 8883932
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation Activity in the Alzheimer's Disease and Normal Brain is Modulated by Microtubule-Associated Protein, Tau in Vitro.
Pant MK; V V; Amin ND; Amin N; Pant HC
J Alzheimers Dis; 1999 Oct; 1(3):169-182. PubMed ID: 12214002
[TBL] [Abstract][Full Text] [Related]
14. Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains.
Khatoon S; Grundke-Iqbal I; Iqbal K
FEBS Lett; 1994 Aug; 351(1):80-4. PubMed ID: 8076698
[TBL] [Abstract][Full Text] [Related]
15. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
Delacourte A; Flament S; Dibe EM; Hublau P; Sablonnière B; Hémon B; Shérrer V; Défossez A
Acta Neuropathol; 1990; 80(2):111-7. PubMed ID: 2117840
[TBL] [Abstract][Full Text] [Related]
16. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain.
Swatton JE; Sellers LA; Faull RL; Holland A; Iritani S; Bahn S
Eur J Neurosci; 2004 May; 19(10):2711-9. PubMed ID: 15147305
[TBL] [Abstract][Full Text] [Related]
17. Phosphoprotein phosphatase activities in Alzheimer disease brain.
Gong CX; Singh TJ; Grundke-Iqbal I; Iqbal K
J Neurochem; 1993 Sep; 61(3):921-7. PubMed ID: 8395566
[TBL] [Abstract][Full Text] [Related]
18. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain.
Pei JJ; Tanaka T; Tung YC; Braak E; Iqbal K; Grundke-Iqbal I
J Neuropathol Exp Neurol; 1997 Jan; 56(1):70-8. PubMed ID: 8990130
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
Vincent I; Jicha G; Rosado M; Dickson DW
J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
Baum L; Hansen L; Masliah E; Saitoh T
Mol Chem Neuropathol; 1996; 29(2-3):253-61. PubMed ID: 8971700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
